Cargando…
Paclitaxel and cisplatin chemotherapy for ovarian cancer during pregnancy: case report and review of the literature
The safety of chemotherapy during pregnancy is debatable. We present a case of advanced ovarian cancer, diagnosed at week 28 of gestational age, treated with 2 cycles of paclitaxel/cisplatin (TC) chemotherapy during pregnancy, with no serious toxicity. At week 34, the patient underwent a caesarean s...
Autores principales: | Serkies, Krystyna, Węgrzynowicz, Ewa, Jassem, Jacek |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3070876/ https://www.ncbi.nlm.nih.gov/pubmed/21369726 http://dx.doi.org/10.1007/s00404-011-1855-4 |
Ejemplares similares
-
The role of hormonal factors and endocrine therapy in ovarian cancer
por: Serkies, Krystyna, et al.
Publicado: (2013) -
Genetic polymorphisms and ovarian cancer risk and response to paclitaxel/cisplatin chemotherapy
por: Tecza, Karolina, et al.
Publicado: (2015) -
Pulsed-dose-rate peri-operative brachytherapy as an interstitial boost in organ-sparing treatment of breast cancer
por: Serkies, Krystyna, et al.
Publicado: (2016) -
Castleman’s disease mimicking lymph node metastases in a young woman with laryngeal cancer
por: Serkies, Krystyna, et al.
Publicado: (2016) -
Genetic polymorphisms and gene-dosage effect in ovarian cancer risk and response to paclitaxel/cisplatin chemotherapy
por: Tecza, Karolina, et al.
Publicado: (2015)